An Update on BRAF Inhibitors and Other New Molecular Targets for the Treatment of Malignant Melanoma of the Skin

Clinical Medicine Insights: Dermatology
doi 10.4137/cmd.s11306
Full Text
Abstract

Available in full text

Date
Authors
Publisher

CLOCKSS Archive

Related search

The Diagnosis and Treatment of Malignant Melanoma of the Skin

Postgraduate Medical Journal
Medicine
1963English

Targeting the Cellular Signaling: BRAF Inhibition and Beyond for the Treatment of Metastatic Malignant Melanoma

Dermatology Research and Practice
Dermatology
2012English

An Update on the Safety of Nivolumab for the Treatment of Advanced Melanoma

Expert Opinion on Drug Safety
MedicinePharmacology
2020English

Toward New Targets for the Diagnosis and Treatment of Malignant Diseases

Wiener Medizinische Wochenschrift
Medicine
2014English

Oral Malignant Melanoma: A Report of Two Cases With BRAF Molecular Analysis

Oncology Letters
Cancer ResearchOncology
2014English

Molecular Characterization of Malignant Mesothelioma: Time for New Targets?

Cancer Discovery
Oncology
2018English

Update on the Clinical Use of Kinase Inhibitors in Melanoma

JDDG - Journal of the German Society of Dermatology
Dermatology
2017English

Distinct Molecular Profiles and Immunotherapy Treatment Outcomes of V600E and V600K BRAF-Mutant Melanoma

Clinical Cancer Research
Cancer ResearchOncology
2019English

Fast Diagnostics of BRAF Mutations in Biopsies From Malignant Melanoma

Nano Letters
Materials ScienceCondensed Matter PhysicsMechanical EngineeringNanoscienceBioengineeringNanotechnologyChemistry
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy